Artificial intelligence model finds potential drug molecules a thousand times faster

A geometric deep-learning model is faster and more accurate than state-of-the-art computational models, reducing the chances and costs of drug trial failures.

algorithms artificial artificial intelligence bioengineering and biotechnology drug development drug discovery intelligence jameel clinic machine learning medicine mit schwarzman college of computing molecules pharmaceuticals research school of engineering